Sara Hylwa is a Dermatology physician affiliated with University of Minnesota. OpenAlex indexes 114 publications with 1,030 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
715 S 8th St
Minneapolis, MN 554047530
Telephone
612-873-6963Provider last certified this registry record 10 Jul 2024.
Clinical trials
- Patient Experience and Quality of Patch Testing on the Legs vs Back
Sponsor: HealthPartners Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Allerderm LaboratoriesProgram year20251 payment
- Allerderm LaboratoriesProgram year20241 payment
- Allerderm LaboratoriesProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
28.6%Azole Antifungal17.6%Ketoconazole88%Fluconazole12%Part D<11 patientsLincosamide Antibacterial5.9%Clindamycin Phosphate100%Part D≥12 patients+ 2 more classes in this area
Dermatology
25%Corticosteroid20%Triamcinolone Acetonide87%Fluocinolone Acetonide13%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist5%Dupixent Pen100%Part D<11 patientsCancer & immunology
20.7%Calcineurin inhibitor6.8%Tacrolimus100%Part D≥15 patientsRetinoid6%Tretinoin100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Blazar, MD
University of Minnesota
Jay Cohn, MD
University of Minnesota
Julia Steinberger, MD
University of Minnesota
Charles Herzog, MD
University of Minnesota
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”